Bio-Rad Laboratories (BIO-B) EPS (Weighted Average and Diluted) (2009 - 2026)
Bio-Rad Laboratories (BIO-B) reported EPS (Weighted Average and Diluted) of -$19.55 for Q1 2026, down 953.71% year-over-year from $2.29 in Q1 2025, and down 174.08% quarter-over-quarter from $26.39 in Q4 2025.
Bio-Rad Laboratories (BIO-B) EPS (Weighted Average and Diluted) (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO-B) has 18 years of EPS (Weighted Average and Diluted) data on file, last reported at -$19.55 in Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$19.55, down 953.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.81 (up 107.62% YoY), and the FY2025 annual result was $27.85, up 142.61% from the prior year.
- EPS (Weighted Average and Diluted) retreated to -$19.55 in Q1 2026 per BIO-B's latest filing, from $26.39 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $27.78 in Q4 2022 and troughed at -$112.5 in Q1 2022.
- A 5-year average of -$11.75 and a median of $2.29 in 2025 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2024 and 2026: EPS (Weighted Average and Diluted) jumped 541.21% in 2024, then plunged 953.71% in 2026.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $27.78 in 2022, then slumped by 56.3% to $12.14 in 2023, then sank by 310.63% to -$25.57 in 2024, then jumped by 203.21% to $26.39 in 2025, then plunged by 174.08% to -$19.55 in 2026.
- Business Quant data shows BIO-B's EPS (Weighted Average and Diluted) at -$19.55 in Q1 2026, $26.39 in Q4 2025, and -$12.7 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 2.24 |
| 10 | Bio-Rad Laboratories | - | - | 309.40 Mn | -19.55 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.55 |
| Dec 31, 2025 | 26.39 |
| Sep 30, 2025 | -12.70 |
| Jun 30, 2025 | 11.67 |
| Mar 31, 2025 | 2.29 |
| Dec 31, 2024 | -25.57 |
| Sep 30, 2024 | 23.34 |
| Jun 30, 2024 | -76.26 |
| Mar 31, 2024 | 13.45 |
| Dec 31, 2023 | 12.14 |
| Sep 30, 2023 | 3.64 |
| Jun 30, 2023 | -39.59 |
| Mar 31, 2023 | 2.32 |
| Dec 31, 2022 | 27.78 |
| Sep 30, 2022 | -5.48 |
| Jun 30, 2022 | -31.05 |
| Mar 31, 2022 | -112.50 |
| Dec 31, 2021 | -52.54 |
| Sep 30, 2021 | 130.02 |
| Jun 30, 2021 | 30.41 |